Coronary disease & ACSSecondary analysis

Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial

Eur Heart JPublished

  • Secondary analysis of the POST-PCI randomised trial
  • randomisation stratified by diabetes status

Authors' conclusion

Despite being at higher risk for adverse clinical events, patients with diabetes who had undergone high-risk PCI did not derive incremental benefit from routine surveillance stress testing compared with standard care alone during follow-up.

Study context

Population
High-risk patients after percutaneous coronary intervention (PCI), with and without diabetes660 with diabetes
Participants
1,706 patients
Comparison
Routine functional testing vs Standard care
Primary endpoint
Composite of:
  • All-cause death
  • MI
  • Hospitalization for unstable angina
Follow-up
2 years

Primary result

As reported in the abstract

Primary composite outcome, by diabetes status (subgroups)
Routine functional testing vs Standard careHazard ratio (95% CI)P value
diabetes: 7.1% vs 7.5%
0.94(0.53–1.66)
P = 0.82
no diabetes: 4.6% vs 5.1%
0.89(0.51–1.55)
P = 0.68

Further findings

OutcomeHR (95% CI)P value
Primary composite outcome, diabetes vs no diabetes1.52 (1.02–2.27)P = 0.039

Invasive coronary angiography and repeat revascularization after 1 year

Higher with routine functional testing than standard care irrespective of diabetes status

Original publication

Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial. Eur Heart J. Published 2 November 2023. doi:10.1093/eurheartj/ehad722

Summarised from the published abstract; every number is checked against it